Cancer Therapies and Cardiomyocyte Viability: Which Drugs are Directly Cardiotoxic?

- Balachandran, Lohis, Haw, Tatt Jhong, Leong, Angeline Jia Wen, Croft, Amanda J., Chen, Dongqing, Kelly, Conagh, Sverdlov, Aaron L., Ngo, Doan T. M.

Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative

- Teske, Arco J., Moudgil, Rohit, Sverdlov, Aaron L., Cheng, Richard K., Makhoul, Silvia, Ghosh, Arjun K., Szmit, Sebastian, Zaha, Vlad, Addison, Daniel, Zhang, Lili, Herrmann, Joerg, Chong, Jun H., López-Fernández, Teresa, Agarwala, Vivek, Iakobishvili, Zaza, Guerrero, Patricia, Yang, Eric H., Leja, Monika, Akhter, Nausheen, Guha, Avirup, Okwuosa, Tochukwu M., Silva, Carolina C., Collier, Patrick, Barac, Ana, DeCara, Jeanne, Bauer, Brenton, Lenneman, Carrie E., Sadler, Diego, Brown, Sherry Ann, Deswal, Anita, Neilan, Tomas G., Ganatra, Sarju, Abdel Qadir, Husam, Menon, Venu

Open-source, fully-automated hybrid cardiac substructure segmentation: development and optimisation

- Finnegan, Robert N., Chin, Vicky, Chlap, Phillip, Haidar, Ali, Otton, James, Dowling, Jason, Thwaites, David I., Vinod, Shalini K., Delaney, Geoff P., Holloway, Lois

Cardiotoxicity of radiation therapy: mechanisms, management, and mitigation

- Ell, P., Martin, J. M., Cehic, D. A., Ngo, D. T. M., Sverdlov, A. L.

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

- Lyon, Alexander R., Dent, Susan, Stanway, Susannah, Earl, Helena, Brezden-Masley, Christine, Cohen-Solal, Alain, Tocchetti, Carlo G., Moslehi, Javid J., Groarke, John D., Bergler-Klein, Jutta, Khoo, Vincent, Tan, Li Ling, Anker, Markus S., von Haehling, Stephan, Maack, Christoph, Pudil, Radek, Barac, Ana, Thavendiranathan, Paaladinesh, Ky, Bonnie, Neilan, Tomas G., Sverdlov, Aaron L.

Anthracycline-induced cardiotoxicity: time to focus on cardioprotection again

- Croft, A. J., Ngo, D. T. M., Sverdlov, A. L.

Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity

- Khan, Arshad A., Ashraf, Asma, Singh, Rajinder, Rahim, Aadil, Rostom, Walid, Hussain, Mumtaz, Renner, Ian, Collins, Nicholas J.

Calcium channel blockers

- Whyte, Ian, Buckley, Nick, Dawson, Andrew